These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32660332)

  • 41. Safety of intranasal corticosteroids for allergic rhinitis in children.
    Zhang M; Ni JZ; Cheng L
    Expert Opin Drug Saf; 2022 Jul; 21(7):931-938. PubMed ID: 35199623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis.
    Skoner DP; Gentile D; Angelini B; Kane R; Birdsall D; Banerji D
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):56-62. PubMed ID: 12546339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The tall and the short: Repainting the landscape about the growth effects of inhaled and intranasal corticosteroids.
    Skoner DP
    Allergy Asthma Proc; 2016 May; 37(3):180-91. PubMed ID: 26935232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benefit and risk management for steroid treatment in upper airway diseases.
    Krahnke J; Skoner D
    Curr Allergy Asthma Rep; 2002 Nov; 2(6):507-12. PubMed ID: 12359122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Iatrogenic Cushing's syndrome following short-term intranasal steroid use.
    Dutta D; Shivaprasad KS; Ghosh S; Mukhopadhyay S; Chowdhury S
    J Clin Res Pediatr Endocrinol; 2012 Sep; 4(3):157-9. PubMed ID: 22985615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review.
    Sarnes E; Crofford L; Watson M; Dennis G; Kan H; Bass D
    Clin Ther; 2011 Oct; 33(10):1413-32. PubMed ID: 21999885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children.
    Boner AL
    J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S32-9. PubMed ID: 11449204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychiatric adverse effects of pediatric corticosteroid use.
    Drozdowicz LB; Bostwick JM
    Mayo Clin Proc; 2014 Jun; 89(6):817-34. PubMed ID: 24943696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology.
    Bielory L; Blaiss M; Fineman SM; Ledford DK; Lieberman P; Simons FE; Skoner DP; Storms WW; ;
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):514-25. PubMed ID: 16680921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of inhaled and intranasal corticosteroids.
    Ahmadiafshar A; Ahmadiafshar S
    Antiinflamm Antiallergy Agents Med Chem; 2014; 13(2):83-7. PubMed ID: 25175908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Injectable Ketorolac and Corticosteroid Use in Athletes: A Systematic Review.
    Jelsema TR; Tam AC; Moeller JL
    Sports Health; 2020; 12(6):521-527. PubMed ID: 32877323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray.
    Schenkel EJ; Skoner DP; Bronsky EA; Miller SD; Pearlman DS; Rooklin A; Rosen JP; Ruff ME; Vandewalker ML; Wanderer A; Damaraju CV; Nolop KB; Mesarina-Wicki B
    Pediatrics; 2000 Feb; 105(2):E22. PubMed ID: 10654982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety, tolerability, pharmacokinetics, and pharmacodynamics of compound SFDAC by intranasal administration of multiple escalating dose in healthy male subjects.
    Thennati R; Khanna A; Khanna M; Sonaiya T; Mehta T; Mehta K; Shahi P; Patel J
    Clin Pharmacol Drug Dev; 2014 Nov; 3(6):428-38. PubMed ID: 27129118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
    Gradman J; Caldwell MF; Wolthers OD
    Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 2. Review of the literature.
    Chrousos GP; Harris AG
    Neuroimmunomodulation; 1998; 5(6):288-308. PubMed ID: 9762011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids (Part 2)--the risk as determined by gold standard adrenal function tests: a systematic review.
    Zöllner EW
    Pediatr Allergy Immunol; 2007 Sep; 18(6):469-74. PubMed ID: 17680905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enteral nutritional therapy for induction of remission in Crohn's disease.
    Zachos M; Tondeur M; Griffiths AM
    Cochrane Database Syst Rev; 2007 Jan; (1):CD000542. PubMed ID: 17253452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.